MedPath
TGA Approval

CYSTADROPS - mercaptamine (cysteamine) (as hydrochloride) 3.8 mg/mL eye drops solution vial (351010)

351010

CYSTADROPS - mercaptamine (cysteamine) (as hydrochloride) 3.8 mg/mL eye drops solution vial

Recordati Rare Diseases Australia Pty Ltd

January 28, 2022

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/7e8cce02a0e400f85ad7159199e222d2.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/24b2d0bc22a9ae3c4724b4cd822c0f84.pdf

Active Ingredients

mercaptamine (cysteamine)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CYSTADROPS - mercaptamine (cysteamine) (as hydrochloride) 3.8 mg/mL eye drops solution vial (351010) - TGA 批准文号 | MedPath